Eli Lilly and Company (NYSE:LLY) develops and markets pharmaceuticals for diabetes, oncology, immunology, neuroscience, and other therapeutic areas worldwide.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 37% bearish. Among these notable options, 3 are puts, totaling $414,097, and 5 are calls, amounting to ...
Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...
Minnesota Attorney General Keith Ellison and pharmaceutical company Novo Nordisk reached a settlement to cap insulin costs at $35 per month. The Novo Nordisk settlement reached on Jan. 27 ...
Barchart on MSN17h
Bank of America: 3 Stocks to Buy for Future Stock Split PotentialDetailed price information for Meta Platforms Inc (META-Q) from The Globe and Mail including charting and trades.
BRISBANE, Australia & INDIANAPOLIS, IN, USA I 10, 2025 I AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback